CIK 0001034842
- Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943248524
- Phone
- +1 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP, Chief Commercial Officer sold 14,519 shares at an average $1.14 ($16,496)
- 4 Open-market sale EVP & Chief Financial Officer sold 12,628 shares at an average $1.14 ($14,338)
- 4 Open-market sale CEO, President sold 52,894 shares at an average $1.14 ($60,082)
- 4 Grant or award EVP, GC, CCO & Corp Sec acquired 209,000 shares (grant or award)
- 4 Grant or award CEO, President acquired 400,000 shares (grant or award)
- 4 Grant or award EVP, Chief Commercial Officer acquired 209,000 shares (grant or award)
- 4 Grant or award EVP & Chief Financial Officer acquired 209,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
- 4 Grant or award Director acquired 25,000 shares (grant or award)
Page 5 of 34 · 664 filings